Upadacitinib Induction and Maintenance Therapy Improves Abdominal Pain, Bowel Urgency, and Fatigue in Patients With Ulcerative Colitis: A Post Hoc Analysis of Phase 3 Data.

Upadacitinib Induction and Maintenance Therapy Improves Abdominal Pain, Bowel Urgency, and Fatigue in Patients With Ulcerative Colitis: A Post Hoc Analysis of Phase 3 Data. Inflamm Bowel Dis. 2023 11 02; 29(11):1723-1729.

View in: PubMed

subject areas

Abdominal Pain
Chronic Disease
Colitis, Ulcerative
Double-Blind Method
Heterocyclic Compounds, 3-Ring
Humans
Treatment Outcome

authors with profiles

David T. Rubin